Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $201 to $208.
Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $201 to $208.